Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety
Conclusion: The efficacy of low-dose alteplase intravenous thrombolytic therapy for AIS was equivalent to the standard-dose regimen but with higher safety.Eur Neurol 2018;79:68 –73
Source: European Neurology - Category: Neurology Source Type: research
More News: Activase | Brain | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Study | Thrombolytic Therapy | Thrombosis